663 results about "Palmitates" patented technology

The present invention provides a method of treating patients in need of treatment with long acting injectable paliperidone palmitate formulations.

Personal care composition comprising at least one hair growth regulating compound selected from the group consisting of glyceryl dilaurate, apigenin, tetrahydrocurcumin, oleanolic acid, azelaic acid, sulforaphane, canavanine, pyridoxal 5-phosphate, phytic acid, tannic acid, grape seed extract, NG-nitro-L-arginine-methyl ester, benzamidine, sodium butyrate, betulinic acid, polyornithine, polyarginine, fisetin, jasmonates, methyl-jasmonate, cis-jasmone, caffeic acid phenethyl ester, delphinidin, ethyl abietate, esculetin, sorbic acid methyl ester, canaline, N-formyl-methionine, N-formyl-alanine, taurine, palmitoyl carnitine, undecanol, undecylenic acid, rutin, fusidic acid, phenyl pyruvic acid, L-isoleucine, phenyl glycine, silibinin, silymarin, L-ascorbic acid-6-palmitate, N-undecylenoyl-L-phenylalanine, and salts, derivatives and mixtures of any of the foregoing; and a dermatologically-acceptable carrier.

The present invention relates to a fungal C16 / 18 fatty acid elongase that is able to catalyze the conversion of palmitate (16:0) to stearic acid (18:0). Specifically, the nucleotide sequence of a Mortierella alpina C16 / 18 fatty acid elongase is provided (designated as “ELO3”). Methods of increasing microbial oil production, increasing carbon flux into the polyunsaturated fatty acid biosynthetic pathway and increasing the content of polyunsaturated fatty acids by over-expression of the C16 / 18 fatty acid elongase are described herein. Most desirably, the substrate specificity of the instant ELO3 will be particularly useful to enable accumulation of long-chain polyunsaturated fatty acids in oleaginous yeast, such as Yarrowia lipolytica.

The present invention relates to a fungal C16 / 18 fatty acid elongase that is able to catalyze the conversion of palmitate (16:0) to stearic acid (18:0). Specifically, the nucleotide sequence of a Mortierella alpina C16 / 18 fatty acid elongase is provided (designated as “ELO3”). Methods of increasing microbial oil production, increasing carbon flux into the polyunsaturated fatty acid biosynthetic pathway and increasing the content of polyunsaturated fatty acids by over-expression of the C16 / 18 fatty acid elongase are described herein. Most desirably, the substrate specificity of the instant ELO3 will be particularly useful to enable accumulation of long-chain polyunsaturated fatty acids in oleaginous yeast, such as Yarrowia lipolytica.

A method for administering an antioxidant composition to humans according to their age and sex is disclosed wherein the method comprises administering to said humans a daily dose of a multiple antioxidant micronutrient composition comprising vitamin A (palmitate), beta carotene (from natural d. salina), vitamin C (calcium ascorbate), vitamin D-3 (cholecalciferol), natural source vitamin E including both d-alpha tocopheryl and d-alpha tocopheryl acid succinate, thiamine mononitrate, riboflavin, niacinamide ascorbate, d-calcium pantothenate, pyridoxine hydrochloride, cyanocobalamin, folic acid (folacin), d-biotin, selenium (1-seleno methionine), chromium picolinate, zinc glycinate, calcium citrate, and magnesium citrate. For persons over the age of about 51, the composition preferably further comprises one or more of co-enzyme Q10, N-acetyl cysteine, and alpha lipoic acid. Preferably, also, vitamin D is added for women over the age of about 36.

The invention relates to a compound antioxidant, which is prepared from vitamin E, tea polyphenol-palmitate, ascorbyl palmitate and a rosemary extract. According to the compound antioxidant, the content of the vitamin E is smaller than or equal to 3,000ppm and greater than or equal to 5ppm, the content of the tea polyphenol-palmitate is smaller than or equal to 600ppm and greater than or equal to 5ppm, the content of the ascorbyl palmitate is smaller than or equal to 200ppm and greater than or equal to 5ppm and the content of the rosemary extract is smaller than or equal to 700ppm and greater than or equal to 5ppm; the content of the vitamin E is calculated according to the total content of mixed tocopherol; and the content of the rosemary extract is calculated according to the content of carnosic acid in the rosemary extract. The compound antioxidant is high in stability and high in antioxidant activity, and can be applied to vegetable fat, animal fat, margarine, oleomargarine or shortening.

The invention discloses a content analysis and detection method of twelve compound vitamins for injection. Liposoluble components including vitamin A palmitate, vitamin D3 and racemic alpha-tocopherol are detected under the same high-performance liquid phase method conditions, a test solution is prepared by extracting a preparation content by non-polar organic solvent, and the detection wavelength is 265+ / -3nm. Water-soluble components including cocarboxylase tetrahydrate, riboflavin sodium phosphate, vitamin B6, vitamin C, nicotinamide, folic acid and dexpanthenol are detected under the same high-performance liquid phase method conditions, and the detection wavelength is 210+ / -3nm. Biotin and vitamin B12 are subjected to high-performance liquid phase method based detection, the detection wavelength is 200-600nm, and the preferable detection wavelength for the vitamin B12 is 550+ / -3nm. The method has high applicability.

The present invention discloses cigarette with tobacco encircled with two, one inner and one outer, layers of cigarette paper. The inner layer of cigarette paper contains inorganic stuffing 20-40 wt%, combustion assistant 6-10 wt% and essence 12-18 wt%; and the outer layer of cigarette paper contains inorganic stuffing 25-35 wt% and combustion assistant 5-10 wt%. The said inorganic stuffing is calcium carbonate, magnesium hydroxide, magnesia, trihydroxyl aluminum or their mixture; the combustion assistant is the mixture of potassium citrate and sodium citrate with weight ratio between potassium ion and sodium ion of 2-4; and the essence is one of menthyl palmitate, vanillin, menthyl carbonate and beta-carotene. The present invention can reduce the side flow fume of cigarette, lower tar and reduce fragrance loss.

The invention relates to an algal oil DHA (Docosahexaenoic Acid) microcapsule, which consists of algal oil DHA, an antioxidant and a shell material. The antioxidant is prepared from VC (Vitamin C) palmitate, lecithin, carnosic acid, VE (Vitamin E) grease and citric acid based on the mass ratio of (40-60):(25-35):(5-10):(3-7):1 sequentially, and the dose of the antioxidant is 0.6-1.2% of the mass of the algal oil DHA; the shell material is prepared from modified starch, Arabic gum, cane sugar, maltose and vitamin C-sodium based on the mass ratio of (10-30):(5-10):(1-5):(1-3):1 sequentially, and the dose of the shell material is 60-70% of the mass of the algal oil DHA. The invention further discloses a preparation method of the algal oil DHA. According to the invention, the oxidation of the algal oil DHA is effectively slowed down, odor smell is covered, the stability of products is increased and the effect duration is prolonged.

The invention relates to a method for preparing a composition containing 2-palmitin. The method comprises the steps of providing a glyceride containing a palmitate residue; mixing the glyceride containing the palmitate residue with palmitic acid, palmitate or palmitic acid non-glyceride, and performing ester exchange to obtain grease A; performing enzymatic directional ester exchange on the grease A and unsaturated fatty acid or non-glyceride of the unsaturated fatty acid to obtain mixed oil B; refining the mixed oil B to obtain the composition containing 2-palmitin. The preparation process is simple. Compared with the existing method, the method disclosed by the invention has the advantages that the content of palmitic acid at the second site in the product prepared by using the method is higher, and fewer byproducts are produced after preparation, so that the method is favorable for environment friendliness.

The invention provides a structural type triglyceride rich in medium-chain fatty acid and a preparation method thereof. The provided triglyceride is prepared from medium-chain fatty acid with a carbon number of 8-12, palmitic acid, glycerin, and long-chain unsaturated fatty acid / fatty acid ester through catalytic reactions. In the provided triglyceride, medium-chain fatty acid accounts for 11 to 40 wt% of total fatty acid; Sn-2 position saturated fatty acid accounts for 52 to 80 wt% of total saturated fatty acid; Sn-1,3 position unsaturated fatty acid accounts for 80 to 95 wt% of total unsaturated fatty acid, the content of Sn-USU type triglyceride is 40 to 80%, and the content of triglyceride palmitate is 3 to 8%. The provided triglyceride has the characteristics of medium-chain triglyceride and long-chain triglyceride; compared with the common medium / long-chain fatty acid edible oil, the provided triglyceride has richer structures, according to the product characteristics, and the provided triglyceride can be used as a food nutrient supplement and added in different food formulas. The preparation method has the characteristics of high production efficiency, low energy consumption, mild reaction conditions, little using amount of enzyme, more precise procedure, and effectively-reduced cost.

The invention discloses a method for synthesizing sucrose-6-palmitate by using lipase through catalytic selectivity. The sucrose-6-palmitate is prepared by taking sucrose and palmitic acid vinyl ester as raw materials, the lipase, namely Lipozyme RM IM as a catalyst, and mixed solvent of tert-amyl alcohol and dimethylsulfoxide (DMSO) in a volume ratio of 4:1 as reaction medium through an acylation reaction. By the method, sucrose palmitate which is highly monoesterified is synthesized at high yield, and reaction time is greatly shortened.

The invention discloses a self-emulsifier and use thereof in binary compound tertiary oil recovery. The emulsifier comprises the following components in percentage by mass: 24 to 30 percent of alkyl amido betaine, 9 to 24 percent of carboxylic amino acid type amphoteric nonionic surfactant, 5 to 14 percent of amine oxide surfactant, 1 to 5 percent of fatty alcohol-polyoxyethylene ether, 0.7 to 3.7 percent of polyoxyethylene sorbitan monooleate, 1 to 2.3 percent of nonyl hydroxybenzene polyethoxylate ether, 0.5 to 1.5 percent of fatty acid methyl ester ethoxylate, 0.6 to 3.7 percent of C6 to C8 fatty alcohol , 0.4 to 2.3 percent of triethanolamine, 0.5 percent of monoglycerylester palmitate and the balance of water. The emulsifier prepared by the method emulsifies crude oil under the condition of low shearing force or no external force of a binary compound system and makes an emulsifying system stable.

The invention discloses a color-changeable lipstick and a preparation method thereof. The color-changeable lipstick is prepared from the following components: mineral fat, isodecyl palmitate, candelilla wax, ozokerite, microcrystalline wax, butyrospermum parkii butter, tocopheryl acetate, isononyl isononanoate, hydrogenated polycyclopentadiene, caprylic / capric triglyceride, diisostearyl malate, hydrogenated polyisobutene, polyethylene, CI 45410, yellow No.5 lake, citric acid, silica, commiphora mukul resin extract, astaxanthin, purple coneflower extract and the balance of polyglyceryl-2 triisostearate. The color-changeable lipstick disclosed by the invention has the characteristics of firm and lasting color and luster, good concealing property and good lip-care effect. By adopting the color-changeable lipstick disclosed by the invention, people can experience a joyful feeling caused by lip gloss while enjoying lip treatment.

The invention discloses a method for extracting fish oil from waste sleeve-fish liver. The method comprises the following steps: extracting crude fish oil from the sleeve-fish liver by a water extraction method; mixing the sleeve-fish liver and water according to a mass ratio of (1:1)-(1:3); charging nitrogen and adding L-ascorbic acid-6-palmitate for extraction; and processing the extracted crude fish oil through degumming, deacidification, decoloring, deodorization and the like to obtain the refined fish oil. The method disclosed by the invention prevents the oxidation of unsaturated fatty acid in the fish oil by charging nitrogen or adding L-ascorbic acid-6-palmitate antioxidant, and strictly controls the refining conditions of temperature, time and the like at the same time; all indexes of the refined sleeve-fish oil reach the first-grade requirements of the fish oil SC / T3502-2000 standard; the fish oil extracted by the method not only has high quality, but also is improved in color, appearance and smell; the method has high extraction rate, and is simple to operate and easy to control; and moreover, the method disclosed by the invention comprehensively utilizes the sleeve-fish waste, turns waste into wealth, increases the additional value and purifies environment.

Methods of determining levels of unbound metabolites are disclosed. Probes derived from fatty acid binding protein muteins are described that bind preferentially to a number of unbound metabolites including oleate, stearate, linoleate, palmitate, arachidonate and unconjugated bilirubin. A profile for a patient is determined using one or more of the described probes. The profile is useful in diagnosis of disease, particularly myocardial infarction, non-alcoholic fatty liver disease (NAFLD), diabetes, stroke, sepsis and neonatal jaundice. The responses of multiple probes to a test sample are used to classify the degree of acute coronary syndrome by comparison to multi-probe profiles generated from unstable angina, non ST elevation myocardial infarction, and ST elevation myocardial infarction.

The invention belongs to the field of cosmetics and particularly discloses acne-removing composition and an application thereof to cosmetics. The acne-removing composition is prepared from components in parts by mass as follows: 0.1-0.5 parts of a vitamin A palmitate active matter, 0.1-1 part of an azelaic acid active matter, 0.1-1 part of a salicylic acid active matter and 0.1-1 part of an Asiatic pennywort herb extract, wherein the vitamin A palmitate active matter, the azelaic acid active matter and the salicylic acid active matter adopt active matters prepared by coating vitamin A palmitate, azelaic acid and salicylic acid respectively. The skin care composition can well penetrate skin surface layers to be absorbed and enter deep layers; all the components are matched in a specific proportion, and multiple contained effect ingredients are blended and cooperate with one another, so that the composition can play comprehensive roles in stripping aged cutin, dredging pores, inhibiting bacteria, diminishing inflammations, controlling oil, promoting metabolism, clearing pigmentation caused by acne and has the excellent acne removal and skin care effect.

The present invention relates to a vitamin A liposome artificial tears eye drops for preventing and curing xerophthalmia and ophthalmokopia. Its composition includes fat-soluble vitamin A, liposome encapsulating material, vitamin E and artificial tears hydrated liquor, in which the fat-soluble vitamin A is vitamin A palmitate or vitamin A acetate, the liposome encapsulating material is soya bean lecithin and cholesterol, and the composition of artificial tears hydrated liquor includes sodium hydrogen carbonate, sodium chloride, glucose, potassium chloride, calcium chloride and water. Besides, according to requirements one or several kinds of auxiliary components of menthanol, PVP and HPMC, etc. also can be added.

The present invention is directed to methods and compositions for treating pulmonary disease comprising delivering directly to a patient's lungs a therapeutically effective amount of oxybutynin in combination with one or more pharmaceutically effective agents. Oxybutynin may be selected from the group consisting of, but not limited to, a xinafoate salt, a palmitate salt, a pamoic salt, a resonate salt, a laurate salt and other salts. The pharmaceutically effective agents comprise bronchodilators, antiinflammatories, corticosteroids, corticosteroid reversal agent or alveolar growth agents or other agents selected from proteinase or protease inhibitors.

An inkjet ink is provided, which produces a print that does not stick to a print printed by a plane paper copier or a laser printer even when these prints are laid on each other with the printed surfaces thereof facing each other. The inkjet ink comprises at least a pigment and a solvent, wherein 30 to 70% by weight of the solvent is constituted by a non-polar solvent, and 20% by weight or more of the solvent is constituted by an ester solvent having an α value of 6° to 8°, preferably 7° to 8°. Preferably, the ester solvent is at least one member selected from the group consisting of isooctyl palmitate, isooctyl isopalmitate and 2-octyldodecyl pivalate.

An organic skin moisturizer comprised of Sea Buckthorn seed oil, Camellia seed oil, Argan seed oil, Pomegranate seed oil, Rosemary essential oil, d-alpha tocopherol, Tea Tree oil, Helichrysum oil, vitamin A palmitate. A lighter organic skin moisturizer comprised of Sea Buckthorn seed oil, Camellia seed oil, Argan seed oil, Pomegranate seed oil, Meadowfoam seed oil, Jojoba oil, d-alpha tocopherol, and Rosemary essential oil. And a damaged skin moisturizer, comprised of Sea Buckthorn seed oil, Tamanu oil, Meadowfoam seed oil, d-alpha tocopherol, Tea tree oil, and Vetiver oil.

A hearing health micronutrient formulation is provided and the formulation comprises dietary antioxidants and endogenous antioxidants, and the dietary antioxidants are selected from a group consisting essentially of Vitamin A (Palmitate), Vitamin E, Vitamin C (Calcium Ascorbate), Vitamin D3 (Cholecalciferol), B Vitamins, Biotin, Pantothenic Acid (as D-Calcium Pantothenate), Calcium Citrate, Magnesium Citrate, Zinc Glycinate, Selenium (Seleno-L-Methionine), Chromium (as Chromium Picolinate), Mixed Carotenoids and mixtures thereof, and the endogenous antioxidants are selected from a group consisting essentially of N-Acetyl Cysteine (NAC), Coenzyme Q10, R-alpha Lipoic Acid, L-Carnitine and mixtures thereof,

The invention relates to a method for synthesizing vitamin A palmitate in a non-water-phase system by using immobilized esterase E.coli BioH as a catalyst. The method comprises the following steps: converting raw materials vitamin A acetate and lower alcohol into vitamin A alcohol by using immobilized esterase E.coli BioH as a catalyst, and carrying out esterification reaction with palmitic acid under non-water-phase conditions by using the immobilized esterase E.coli BioH as a catalyst to obtain the vitamin A palmitate. The conversion rate of the method is up to 98% above, the number of enzyme recycling times can reach more than 40, the subsequent product separation and purification process is simple, and the production cost is lower, thereby being beneficial to implementing industrialization. The vitamin A palmitate prepared by the method is light yellow grease on the appearance. The analysis by the United States Pharmacopeia USP28 process proves that the potency is 1.79-1.8 million IU / g, which the equivalent to the content of 98-99%; and the vitamin A palmitate can be widely used as a drug, feed additive, food additive or the like.

The invention discloses a textile auxiliary containing antibiotic constituents. The textile auxiliary comprises, by weight parts, 50-60 parts of sodium diethylhexyl sulfosuccinate, 45-55 parts of polyvinyl pyrrolidone, 40-50 parts of sodium dodecyl sulfonate, 30-40 parts of hydroxyethyl sulfonate, 30-40 parts of 2-hydroxyethyl salicylate, 25-35 parts of lupenyl palmitate, 25-35 parts of styrene maleic anhydride resin, 15-25 parts of trichloro-sym-diphenylurea, 15-25 parts of ethyl vanillin, 5-10 parts of zinc oxide, 5-10 parts of cross-linking agent and 5-10 parts of softening agent. The textile auxiliary containing the antibiotic constituents improves antibiotic effects of textile, and further has antifouling function. A corresponding preparation method is further disclosed.

The invention relates to a hyperbranched polyester-modified polyurethane medical interventional catheter and a manufacturing method thereof. A catheter body of the catheter is made from a mixed fused material of hyperbranched polyester which contains carboxyl groups and palmitate groups in end groups thereof and a thermoplastic polyurethane elastomer, wherein a hydrophilic coating, which is in covalent bond connection to the catheter, is coated on the outer surface of the catheter; and the hydrophilic coating includes a bottom coating, which can be grated with the outer surface of the catheter, and a top coating which forms a semi-interpenetrating network structure with the bottom coating. According to the medical interventional catheter and the manufacturing method thereof disclosed by the invention, on the basis of the property that the hyperbranched polyester has a great amount of the end groups, and in combination with a chemical bond grating technology between the catheter and the coating as well as a semi-interpenetrating network construction technology between a hydrophilic polymer and the coating, the catheter and the coating are closely combined effectively, so that the manufactured polyurethane medical interventional catheter is excellent in lubricating property and abrasion resistance; and the catheter is applicable to the field of endovascular intervention diagnosis and treatment.

The invention discloses a fat-soluble composite vitamin I composition freeze-dried powder injection. The fat-soluble composite vitamin I composition freeze-dried powder injection is safe and reliable, has stable quality and is prepared from vitamin A palmitate, vitamin K1, vitamin E, vitamin D2, povidone, propyl gallate, polysorbate 80, mannitol and injection water. The fat-soluble composite vitamin I composition freeze-dried powder injection and the preparation method thereof thoroughly solve that the existing fat-soluble composite vitamin freeze-dried powder injection can not be stored for a long time and the content of related substances is very high and can not be controlled so that injection safety problems and active substance degradation problems are caused. In the clinical use, the fat-soluble composite vitamin I composition freeze-dried powder injection is safe, has stable quality and can be stored for a long time.

The invention discloses a water-based acrylic resin. The water-based acrylic resin comprises the following components in parts by weight: 30-32 parts of ethyl acrylate, 10-12 parts of butyl acrylate, 4-5 parts of methyl methacrylate, 1 part of methacrylic acid, 1 part of hydroxyethyl methacrylate, 0.4-1 part of diacetone acrylamide, 0.1-0.3 part of oxalyl dihydrazide, 1 part of triethanolamine, 0.2 part of potassium persulfate, 1.5 parts of butyl palmitate, 2-3 parts of a surfactant, 0.05 part of a defoamer, 0.01 part of a preservative and 40-45 parts of water medium. The water-based acrylic resin is prepared by chemically mixing a pre-emulsion; the elasticity, water resistance, soundness and other indexes of the water-based acrylic resin meet requirements; the prepared adhesive slurry is thick in film, good in fastness, high in water resistance, non-stick in surface, good in stability and extremely environment-friendly; therefore, the water-based acrylic resin is ideal water-based resin.

The invention discloses a fireproof foam brick, which is characterized by being prepared from the following raw materials by weight part: 60-70 of waste glass, 10-15 of asbestos powder, 5-10 of quartz sand, 5-10 of semi-hydrated gypsum, 3-5 of antimony trioxide, 2-4 of aluminium tripolyphosphate, 2-4 of silicon nitride, 1-2 of oxalic acid, 1-2 of zinc borate, 1-2 of potassium sodium tartrate, 0.5-1 of isopropyl myristate, 0.2-0.4 of isooctyl palmitate, 0.5-1 of polyvinyl alcohol, 2-4 of fatty alcohol polyoxyethylene ether sodium sulfate, 2-4 of a modification additive, and 50-60 of water. The foam brick provided by the invention has excellent fireproofness and high temperature resistance, and good heat insulation, and can effectively prevent potential safety hazards.

The invention discloses a formula of DHA algae oil soft-capsules, and relates to the technical fields of medicines and health foods. The formula of the DHA algae oil soft-capsules comprises the following ingredients: 200-250 parts by weight of DHA algae oil, 150-200 parts by weight of linseed oil, 200-250 parts by weight of vitamin A palmitate, 150-200 parts by weight of beeswax, 300-400 parts byweight of soybean oil, 50-80 parts by weight of gelatin, 50-100 parts by weight of glycerine, 20-30 parts by weight of titanium dioxide, 150-250 parts by weight of purified water, and 5-10 parts by weight of a pigment. In addition, the invention further discloses a preparation method of the DHA algae oil soft-capsules adopting the formula. The raw materials and auxiliary materials of the DHA algaeoil soft-capsules synergistically take an effect so as to enhance functions, and thus, the DHA algae oil soft-capsules are capable of promoting brain development and preventing weakening of visual acuity. The preparation method of the DHA algae oil soft-capsules comprises the following steps of proportioning materials, dissolving materials, dissolving gelatin, carrying out pelleting, carrying outshaping, carrying out drying, carrying out packaging, carrying out detecting, carrying out warehousing and so on. The same production line is adopted for treatment during the whole process so that nutrient loss caused by instable factors is avoided; and the whole preparation process is completed in a certain clean area so that clean working environment is ensured, and thus, influence of the environment on the soft-capsules is reduced to the maximum extent.